Psychometric Properties of Iranian version of Irritable Bowel Syndrome- Behavioral Responses Questionnaire (IBS-BRQ)
Gastroenterology and Hepatology from Bed to Bench,
Introduction: In addition to somatic symptoms and complaints, patients with irritable bowel syndrome have specific dysfunctional behaviors that lead to disease persistence and avoid useful function. The aim of this study was determine Psychometric Properties of Iranian version of Irritable Bowel Syndrome- Behavioral Responses Questionnaire (IBS-BRQ).
Method: Participants included 170 patients with irritable bowel syndrome who were diagnosed based on ROM-IV criteria and selected from patients referred to the Gastrointestinal Disorders Clinic, as well as 100 persons from the general population in Isfahan in2020 . Both groups completed the 28-item Irritable Bowel Syndrome-Behavioral Responses Questionnaire (IBS-BRQ). Also Questionnaires including The Irritable Bowel Syndrome Symptom Severity Scale (IBS-SSS), Irritable bowel syndrome-quality of life IBS-QOL, illness perception questionnaire (IPQ-R),Irritable Bowel Syndrome-Patient satisfaction (IBS-SAT), Hope scale, Interpersonal forgiveness scale, and Dysfunctional Attitude Scale- 26-item (DAS-26) were completed to determine the validity of IBS-BRQ. Tests of Internal consistency, principal components analyses(PCAs), differentiation analysis and correlation were used to determine its reliability, criterion and construct validity.
Findings: The IBS-BRQ was found to be valid and reliable in both group with a high degree of internal consistency. In IBS patients (Cronbach's α=.94) and controls (Cronbach's α=.87). The scale differentiated significantly between IBS patients and controls (p<.001). The PCA supported a two-factor solution in IBS patients and one-factor in general papulatin sets of data. The criterion validity was high as evidenced by a high correlation with DAS-26 (r=0.53, Pb.001), IBS-QOL (r=0.76, Pb.001),IBS-SSS(r=0.44, Pb.001), IPQ-R(r=0.56, Pb.001), and revesed corrolation with IPF(r=-.031, Pb.001), IBS-SAT(r=-0.23, Pb.001),HOPE(r=-0.49, Pb.001)
Conclusion: The Persian version of the IBS-BRQ offered a well-defined behavioral response measure in IBS patients with high validity and reliability, making it a suitable measure to employ in future IBS clinical research in Iran.
- psychometric properties
- irritable bowel syndrome
- behavioral responses scale
How to Cite
1. Ford AC, Lacy BE, Talley NJ. Irritable Bowel Syndrome. The New England journal of medicine. 2017;376(26):2566-78.
2. Chitkara DK, van Tilburg MA, Blois-Martin N, Whitehead WE. Early life risk factors that contribute to irritable bowel syndrome in adults: a systematic review. The American journal of gastroenterology. 2008;103(3).
3. Korterink JJ, Diederen K, Benninga MA, Tabbers MM. Epidemiology of pediatric functional abdominal pain disorders: a meta-analysis. PloS one. 2015;10(5):e0126982.
4. Jahangiri P, Jazi MS, Keshteli AH, Sadeghpour S, Amini E, Adibi P. Irritable Bowel Syndrome in Iran: SEPAHAN Systematic Review No. 1. International journal of preventive medicine. 2012;3(Suppl 1):S1-9.
5. Chapple A, Ziebland S, McPherson A. Stigma, shame, and blame experienced by patients with lung cancer: qualitative study. bmj. 2004;328(7454):1470.
6. Jones MP, Keefer L, Bratten J, Taft TH, Crowell MD, Levy R, et al. Development and initial validation of a measure of perceived stigma in irritable bowel syndrome. Psychology, Health & Medicine. 2009;14(3):367-74.
7. Hauser G, Pletikosic S, Tkalcic M. Cognitive behavioral approach to understanding irritable bowel syndrome. World J Gastroenterol. 2014;20(22):6744-58.
8. Lee S-M, Oh S, Kim J, Kim Y-M, Choi Y-K, Kwak HH, et al. Age estimation using the maxillary canine pulp/tooth ratio in Korean adults: A CBCT buccolingual and horizontal section image analysis. Journal of Forensic Radiology and Imaging. 2017;9:1-5.
9. Fichna J, Storr MA. Brain-Gut Interactions in IBS. Frontiers in pharmacology. 2012;3:127.
10. Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196(4286):129-36.
11. Lutgendorf SK, Costanzo ES. Psychoneuroimmunology and health psychology: an integrative model. Brain, behavior, and immunity. 2003;17(4):225-32.
12. Spence M. A prospective investigation of cognitive-behavioural models of irritable bowel and chronic fatigue syndromes: Implications for theory, classification and treatment: ResearchSpace@ Auckland; 2005.
13. van der Veek PP, Dusseldorp E, van Rood YR, Masclee AA. Testing a biobehavioral model of irritable bowel syndrome. European journal of gastroenterology & hepatology. 2010;22(4):412-9.
14. Naliboff BD, Munakata J, Fullerton S, Gracely RH, Kodner A, Harraf F, et al. Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut. 1997;41(4):505-12.
15. Keough ME, Timpano KR, Zawilinski LL, Schmidt NB. The association between irritable bowel syndrome and the anxiety vulnerability factors: body vigilance and discomfort intolerance. Journal of health psychology. 2011;16(1):91-8.
16. Rief W, Barsky AJ. Psychobiological perspectives on somatoform disorders. Psychoneuroendocrinology. 2005;30(10):996-1002.
17. Mayer EA, Labus JS, Tillisch K, Cole SW, Baldi P. Towards a systems view of IBS. Nature Reviews Gastroenterology & Hepatology. 2015;12(10):592-605.
18. Rutten JM, Korterink JJ, Venmans LM, Benninga MA, Tabbers MM. Nonpharmacologic treatment of functional abdominal pain disorders: a systematic review. Pediatrics. 2015;135(3):522-35.
19. Labus J, Bolus R, Chang L, Wiklund I, Naesdal J, Mayer E, et al. The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom‐specific anxiety scale. Alimentary pharmacology & therapeutics. 2004;20(1):89-97.
20. Jerndal P, Ringström G, Agerforz P, Karpefors M, Akkermans L, Bayati A, et al. Gastrointestinal‐specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS. Neurogastroenterology & Motility. 2010;22(6):646-e179.
21. Ebrahimi A, Naddafnia L, Neshatdust HT, Talebi H, Afshar H, Mail HD, et al. The Effectiveness of Cognitive Behavioral Therapy on Symptoms Intensity, Quality of Life, and Mental Health in Patients with Irritable Bowel Syndrome. International Journal of Body, Mind and Culture. 2015:76-84.
22. Toner BB, Stuckless N, Ali A, Downie F, Emmott S, Akman D. The development of a cognitive scale for functional bowel disorders. Psychosomatic Medicine. 1998;60(4):492-7.
23. Reme SE, Darnley S, Kennedy T, Chalder T. The development of the irritable bowel syndrome-behavioral responses questionnaire. Journal of psychosomatic research. 2010;69(3):319-25.
24. Betz C, Mannsdörfer K, Bischoff S. Validation of the IBS-SSS. Zeitschrift fur Gastroenterologie. 2013;51(10):1171-6.
25. Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Digestive diseases and sciences. 1998;43(2):400-11.
26. Weinman J, Petrie KJ, Moss-Morris R, Horne R. The illness perception questionnaire: a new method for assessing the cognitive representation of illness. Psychology and health. 1996;11(3):431-45.
27. Reichardt J, Ebrahimi A, Dehsorkhi HN, Mewes R, Weise C, Afshar H, et al. Why is this happening to me?–a comparison of illness representations between Iranian and German people with mental illness. BMC psychology. 2018;6(1):1-10.
28. Dorn SD, Morris CB, Schneck SE, Hopper TM, Hu YJ, Kelapure R, et al. Development and validation of the irritable bowel syndrome satisfaction with care scale. Clinical Gastroenterology and Hepatology. 2011;9(12):1065-71. e2.
29. Snyder CR, Sympson SC, Ybasco FC, Borders TF, Babyak MA, Higgins RL. Development and validation of the State Hope Scale. Journal of personality and social psychology. 1996;70(2):321.
30. McCullough ME, Fincham FD, Tsang J-A. Forgiveness, forbearance, and time: the temporal unfolding of transgression-related interpersonal motivations. Journal of personality and social psychology. 2003;84(3):540.
31. Ehteshamzadeh P, Ahadi H, Enayati MS, Heidari A. Construct and validation of a scale for measuring interpersonal forgiveness. Iranian journal of psychiatry and clinical psychology. 2011;16(4):443-55.
32. Beck AT, Brown G, Steer RA, Weissman AN. Factor analysis of the Dysfunctional Attitude Scale in a clinical population. Psychological Assessment: A Journal of Consulting and Clinical Psychology. 1991;3(3):478.
33. Ebrahimi A, Samouei R, Mousavii SG, Bornamanesh AR. Development and validation of 26-item dysfunctional attitude scale. Asia-Pacific Psychiatry. 2013;5(2):101-7.
34. Hair J, Black W, Babin B, Anderson R. Multivariate data analysis: Pearson College Division. Pearson Prentice Hall; 2010.
35. Boersma K, Ljótsson B, Edebol-Carlman H, Schrooten M, Linton SJ, Brummer RJ. Exposure-based cognitive behavioral therapy for irritable bowel syndrome. A single-case experimental design across 13 subjects. Cognitive Behaviour Therapy. 2016;45(6):415-30.
36. Reme SE, Kennedy T, Jones R, Darnley S, Chalder T. Predictors of treatment outcome after cognitive behavior therapy and antispasmodic treatment for patients with irritable bowel syndrome in primary care. Journal of psychosomatic research. 2010;68(4):385-8.
37. Van Oudenhove L, Levy RL, Crowell MD, Drossman DA, Halpert AD, Keefer L, et al. Biopsychosocial aspects of functional gastrointestinal disorders: how central and environmental processes contribute to the development and expression of functional gastrointestinal disorders. Gastroenterology. 2016;150(6):1355-67. e2.
38. Hesser H, Hedman-Lagerlöf E, Lindfors P, Andersson E, Ljótsson B. Behavioral avoidance moderates the effect of exposure therapy for irritable bowel syndrome: A secondary analysis of results from a randomized component trial. Behaviour Research and Therapy. 2021;141:103862.
39. Bonnert M, Olén O, Bjureberg J, Lalouni M, Hedman-Lagerlöf E, Serlachius E, et al. The role of avoidance behavior in the treatment of adolescents with irritable bowel syndrome: A mediation analysis. Behaviour Research and Therapy. 2018;105:27-35.
40. Vlaeyen JW, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain. 2000;85(3):317-32.
41. Simons LE, Kaczynski KJ. The fear avoidance model of chronic pain: Examination for pediatric application. The Journal of Pain. 2012;13(9):827-35.
- Abstract Viewed: 0 times